EGFR


The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands.
The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/c-neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). Mutations affecting EGFR expression or activity could result in cancer.
  • Tucatinib EY8041

    Tucatinib (Irbinitinib, ONT-380, ARRY-380) 是一种具有口服活性、可逆的、ATP竞争性的的ErbB2(HER2)小分子抑制剂。在细胞实验中,ARRY-380对ErbB-2和p95 HER2的IC50s分别为8 nM和7 nM,对HER2的选择性是对EGFR的500倍。具有潜在的抗肿瘤活性。

    More
  • ASP8273 EY2847

    ASP8273 is a small molecule, irreversible TKI inhibitor that inhibits the kinase activity of EGFR mutations including T790M, with limited activity against EGFR wild-type NSCLC. In the in vitro enzymatic and cell-based assays, ASP8273 were evaluated against EGFR mutantsand WT EGFR.

    More
  • EGF-816 EY2846

    EGF816 is a third-generation covalent EGFR inhibitor that has potent inhibitory activity against activating and resistant T790M mutants with low IC50 in various cellular assays.

    More
  • HM-71224 EY2845

    HM-71224 is an EGFR tyrosine kinase inhibitor.

    More
  • Erlotinib HCl EY0933

    Erlotinib HCl (OSI-744)是一种EGFR抑制剂,IC50为2 nM,对EGFR的选择性比c-Src或v-Abl高1000倍以上。

    More
  • Tucatinib EY8041

    Tucatinib (Irbinitinib, ONT-380, ARRY-380) 是一种具有口服活性、可逆的、ATP竞争性的的ErbB2(HER2)小分子抑制剂。在细胞实验中,ARRY-380对ErbB-2和p95 HER2的IC50s分别为8 nM和7 nM,对HER2的选择性是对EGFR的500倍。具有潜在的抗肿瘤活性。

    More
  • ASP8273 EY2847

    ASP8273 is a small molecule, irreversible TKI inhibitor that inhibits the kinase activity of EGFR mutations including T790M, with limited activity against EGFR wild-type NSCLC. In the in vitro enzymatic and cell-based assays, ASP8273 were evaluated against EGFR mutantsand WT EGFR.

    More
  • EGF-816 EY2846

    EGF816 is a third-generation covalent EGFR inhibitor that has potent inhibitory activity against activating and resistant T790M mutants with low IC50 in various cellular assays.

    More
  • HM-71224 EY2845

    HM-71224 is an EGFR tyrosine kinase inhibitor.

    More
  • Erlotinib HCl EY0933

    Erlotinib HCl (OSI-744)是一种EGFR抑制剂,IC50为2 nM,对EGFR的选择性比c-Src或v-Abl高1000倍以上。

    More
  • Tucatinib EY8041

    Tucatinib (Irbinitinib, ONT-380, ARRY-380) 是一种具有口服活性、可逆的、ATP竞争性的的ErbB2(HER2)小分子抑制剂。在细胞实验中,ARRY-380对ErbB-2和p95 HER2的IC50s分别为8 nM和7 nM,对HER2的选择性是对EGFR的500倍。具有潜在的抗肿瘤活性。

    More
  • ASP8273 EY2847

    ASP8273 is a small molecule, irreversible TKI inhibitor that inhibits the kinase activity of EGFR mutations including T790M, with limited activity against EGFR wild-type NSCLC. In the in vitro enzymatic and cell-based assays, ASP8273 were evaluated against EGFR mutantsand WT EGFR.

    More
  • EGF-816 EY2846

    EGF816 is a third-generation covalent EGFR inhibitor that has potent inhibitory activity against activating and resistant T790M mutants with low IC50 in various cellular assays.

    More
  • HM-71224 EY2845

    HM-71224 is an EGFR tyrosine kinase inhibitor.

    More
  • Erlotinib HCl EY0933

    Erlotinib HCl (OSI-744)是一种EGFR抑制剂,IC50为2 nM,对EGFR的选择性比c-Src或v-Abl高1000倍以上。

    More
  • Current page1, Total Pages7, Total Record32 First Prev 12345 Next Last Goto